Lung Cancer Stage IV

Screening for Brain Metastases

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor

Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System

Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer

Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)

A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib

Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating

Resilience Measurement in Older Adults With Late-Stage Lung Cancer

Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities

Psychosocial eHealth in Advanced Lung Cancer

The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer

Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs

Lazertinib 160mg in EGFR T790M NSCLC

Self-System Therapy for Older Adults With Lung Cancer

Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay

Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.

A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC